2m 2m 2m 2m 2m 2m 2m
AURA BIOSCIS (AURA)
NASDAQ
$7.27+$0.26 (+3.68%)
Price as of Aug 03, 2026 6:40 AM EDT- $725.1MMarket Cap
- 4.01%1-Year Change
- BiotechnologyIndustry
AURA BIOSCIS (AURA)
$7.27+$0.26 (+3.68%)
AURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.01 | ||
Change | -$0.10 (-1.41%) | ||
Open | $7.01 | ||
High | $7.09 | ||
Low | $6.85 | ||
Previous Close | $7.11 | ||
Volume | 294,063 | ||
30-Day Average Volume | 509,213 | ||
1-Week Change | -0.57% | ||
1-Month Change | -1.27% | ||
1-Year Change | 4.01% | ||
3-Year Change | -41.09% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 103.4M | ||
Total Assets | $137.7M | ||
Market Cap | $725.1M | ||
Enterprise Value | $640.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$33.7M | ||
Free Cash Flow | -$30.0M | ||
EBIT | -$33.7M | ||
EBITDA | -$33.4M | ||
Net Working Capital | $101.8M | ||
EPS | -$0.50 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -14 | ||
PEG | 0 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue